Literature DB >> 2004951

The response of human and rodent cells to hyperthermia.

L Roizin-Towle1, J P Pirro.   

Abstract

Inherent cellular radiosensitivity in vitro has been shown to be a good predictor of human tumor response in vivo. In contrast, the importance of the intrinsic thermosensitivity of normal and neoplastic human cells as a factor in the responsiveness of human tumors to adjuvant hyperthermia has never been analyzed systematically. A comparison of thermal sensitivity and thermo-radiosensitization in four rodent and eight human-derived cell lines was made in vitro. Arrhenius plots indicated that the rodent cells were more sensitive to heat killing than the human, and the break-point was 0.5 degrees C higher for the human than rodent cells. The relationship between thermal sensitivity and the interaction of heat with X rays at low doses was documented by thermal enhancement ratios (TER's). Cells received either a 1 hr exposure to 43 degrees C or a 20 minute treatment at 45 degrees C before exposure to 300 kVp X rays. Thermal enhancement ratios ranged from 1.0 to 2.7 for human cells heated at 43 degrees C and from 2.1 to 5.3 for heat exposures at 45 degrees C. Thermal enhancement ratios for rodent cells were generally 2 to 3 times higher than for human cells, because of the fact that the greater thermosensitivity of rodent cells results in a greater enhancement of radiation damage. Intrinsic thermosensitivity of human cells has relevance to the concept of thermal dose; intrinsic thermo-radiosensitization of a range of different tumor cells is useful in documenting the interactive effects of radiation combined with heat.

Entities:  

Mesh:

Year:  1991        PMID: 2004951     DOI: 10.1016/0360-3016(91)90018-y

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  A targeted approach to cancer imaging and therapy.

Authors:  Chun Li
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

2.  THERMAL DOSE REQUIREMENT FOR TISSUE EFFECT: EXPERIMENTAL AND CLINICAL FINDINGS.

Authors:  Mark W Dewhirst; Benjamin L Viglianti; Michael Lora-Michiels; P Jack Hoopes; Margaret Hanson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2003-06-02

3.  Development of a biodegradable iron oxide nanoparticle gel for tumor bed therapy.

Authors:  Bp Cunkelman; Ey Chen; Aa Petryk; Ja Tate; Sg Thappa; Rj Collier; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-02-26

4.  Development of Novel Magnetic Nanoparticles for Hyperthermia Cancer Therapy.

Authors:  Shiraz M Cassim; Andrew J Giustini; Ian Baker; P Jack Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-23

Review 5.  Image-guided thermal ablation with MR-based thermometry.

Authors:  Mingming Zhu; Ziqi Sun; Chin K Ng
Journal:  Quant Imaging Med Surg       Date:  2017-06

6.  Nanoparticle based cancer treatment: can delivered dose and biological dose be reliably modeled and quantified?

Authors:  P Jack Hoopes; Alicia A Petryk; Andrew J Giustini; Robert V Stigliano; Robert N D'Angelo; Jennifer A Tate; Shiraz M Cassim; Allan Foreman; John C Bischof; John A Pearce; Thomas Ryan
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-23

7.  Comparison of microwave and magnetic nanoparticle hyperthermia radiosensitization in murine breast tumors.

Authors:  Andrew J Giustini; Alicia A Petryk; P Jack Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-22

8.  Evaluation of important treatment parameters in supraphysiological thermal therapy of human liver cancer HepG2 cells.

Authors:  Bhavik Shah; Sankha Bhowmick
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

9.  Comparison of magnetic nanoparticle and microwave hyperthermia cancer treatment methodology and treatment effect in a rodent breast cancer model.

Authors:  Alicia A Petryk; Andrew J Giustini; Rachel E Gottesman; B Stuart Trembly; P Jack Hoopes
Journal:  Int J Hyperthermia       Date:  2013-12       Impact factor: 3.914

Review 10.  Challenges to effective cancer nanotheranostics.

Authors:  Marites P Melancon; R Jason Stafford; Chun Li
Journal:  J Control Release       Date:  2012-08-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.